Dr Reddys Laboratories (RDY) Research & Development (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Research & Development of $54.77 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 23.0% from $71.1 million a year earlier and down 10.1% from the prior quarter.
Dr Reddys Laboratories (RDY) Research & Development (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Dr Reddys Laboratories' Research & Development came in at $244.48 million, down 20.3% year-over-year; for FY2026 (ended Mar 31, 2026), it was $256 million, down 20.0% from FY2025.
- Research & Development has a five-year compound annual growth rate of 2.5% (FY2021 to FY2026).
- By fiscal year, Research & Development came in at $320 million in FY2025 (+16.8%), $274 million in FY2024 (+16.1%), $236 million in FY2023 (+2.6%) and $230 million in FY2022 (+1.8%).
- The fiscal Q2 2027 figure ranks as the lowest quarterly Research & Development since fiscal Q4 2020.
- Year over year, Research & Development has now declined in each of the last six quarters, with an average decline of 10.2% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was fiscal Q4 2024 (growth of 38.0%); the low point was fiscal Q4 2026 (a decline of 28.7%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $60.9 million (Q1 2027), $59.76 million (Q4 2026) and $69.05 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 54.77 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 54.77 Mn |
| Jun 30, 2026 | 60.90 Mn |
| Mar 31, 2026 | 59.76 Mn |
| Dec 31, 2025 | 69.05 Mn |
| Sep 30, 2025 | 71.10 Mn |
| Jun 30, 2025 | 72.96 Mn |
| Mar 31, 2025 | 83.82 Mn |
| Dec 31, 2024 | 78.86 Mn |
| Sep 30, 2024 | 86.81 Mn |
| Jun 30, 2024 | 74.24 Mn |
| Mar 31, 2024 | 82.81 Mn |
| Dec 31, 2023 | 66.84 Mn |
| Sep 30, 2023 | 65.89 Mn |
| Jun 30, 2023 | 66.00 Mn |
| Mar 31, 2023 | 60.00 Mn |
| Dec 31, 2022 | 65.00 Mn |
| Sep 30, 2022 | 59.00 Mn |
| Jun 30, 2022 | 59.00 Mn |
| Mar 31, 2022 | 57.53 Mn |
| Dec 31, 2021 | 57.00 Mn |
Dr Reddys Laboratories Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();